Pubblicazioni

Combination of Asciminib, a Novel and Specific BCR-ABL1 Inhibitor, Plus Imatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results

2019 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Talpaz, Moshe; Cortes, Jorge; Lang, Fabian; Kim, Dong-Wook; RÃ©a, Delphine; Mauro, Michael J.; Minami, Hironobu; Breccia, Massimo; Deangelo, Daniel J.; Hochhaus, Andreas; Tee Goh, Yeow; Le Coutre, Philipp D.; Sondhi, Manu; Mishra, Kaushal; Hourcade-Potelleret, Florence; Vanasse, Gary; Aimone, Paola; Hughes, Timothy P.